OCT-Angiography and Adaptive Optics in Patients With Memory Impairment

NCT ID: NCT04389437

Last Updated: 2025-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-26

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies suggest an association between retinal abnormalities and NCD (Neuro Cognitive Disorders) whether they are linked to proven or prodromal Alzheimer's disease (aMCI : amnestic mild cognitive impairment), or to other neurodegenerative diseases such as frontotemporal dementia or Lewy body diseases.

These retinal anomalies objectified by OCT-A (Optical coherence tomography angiography) and adaptive optics (AO) appear different depending on the pathologies and could therefore serve as markers in vivo of the pathophysiological processes underlying NCD.

No study to date has studied the retina and its vessels in NCD using adaptive optics. In this pilot study, we are proposing a combination of two new ophthalmological imaging techniques (OCT-A and AO), which allow rapid in vivo analysis in a completely non-invasive way of the morphology of small vessels as well as architecture of the retina to better specify the retinal anomalies associated with NCD. We will compare the parameters in OCT-A and AO between patients with NCD and controls without NCD (with memory complaint or without) and will seek to determine if there are different profiles according to the causes of NCD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amnesia Alzheimer Disease Lewy Body Disease Parkinsons Disease With Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NCD patients (case)

Patient diagnosed with Alzheimer's disease or parkinsonian dementia / Lewy body dementia or other mild or severe NCD defined by international criteria.

Group Type EXPERIMENTAL

Ophthalmological exam

Intervention Type PROCEDURE

OCT-A and AO

Blood pressure measurement

Intervention Type PROCEDURE

Blood pressure measurement before the ophthalmological exam

Control patients with memory complaint

Normal neuropsychological evaluation during assessment

Group Type OTHER

Ophthalmological exam

Intervention Type PROCEDURE

OCT-A and AO

Blood pressure measurement

Intervention Type PROCEDURE

Blood pressure measurement before the ophthalmological exam

Control patients without memory complaint

MMS score and / or the Montreal Cognitive Assessment grid (MoCA) ≥26 / 30, No memory complaint

Group Type OTHER

Ophthalmological exam

Intervention Type PROCEDURE

OCT-A and AO

Blood pressure measurement

Intervention Type PROCEDURE

Blood pressure measurement before the ophthalmological exam

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ophthalmological exam

OCT-A and AO

Intervention Type PROCEDURE

Blood pressure measurement

Blood pressure measurement before the ophthalmological exam

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient presenting in memory consultation for memory complaint or person accompanying a patient in memory consultation for memory complaint

Exclusion Criteria

* pregnant or lactating women
* history of known non-degenerative neurological pathology (tumor, stroke territorial, in particular multiple sclerosis)
* history of retinal pathology
* ametropia greater in absolute value than 3 diopters on the sphere, or/and 1.5 diopters on the cylinder.
* history of taking ethambutol for more than 2 months
* history of takingsynthetic antimalarial for more than 2 years
* Mini Mental State Score (MMS) and / or Montreal Cognitive Assessment (MoCA) \<10 for patients and 26 for accompanying persons
* MRI contraindication (for patients only)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antoine MOULIGNIER, MD

Role: PRINCIPAL_INVESTIGATOR

Fondation A. de Rothschild

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Fondation A. de Rothschild

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amélie YACHITZ, MD

Role: CONTACT

(0)148036454 ext. +33

Antoine MOULIGNIER, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Antoine MOULIGNIER, MP

Role: primary

Martine MAUGET FAYSSE, MD

Role: backup

(0)148036437 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AMR_2020_3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Retinal Investigation Using Optos OCT Device
NCT06846151 NOT_YET_RECRUITING NA
Visual Frailty in Ageing
NCT06604104 RECRUITING